APIM Therapeutics
Erlend Skagseth is currently the Managing Partner at Sarsia Seed Management AS which manages the Sarsia Seed Fund. Erlend brings 25 years of experience from R&D based IPR, project and business development from Christian Michelsen Research, Forinnova and Sarsia Innovation. He has managed several turnaround processes and negotiated a large number of international contracts, licenses and trade exits. He is/has also served as a Board Member in several companies including Avexxin, Vaccibody, Geneseque and others.
This person is not in the org chart
This person is not in any offices
APIM Therapeutics
APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).